Kezar Life Sciences enters separation agreement with former CMO Noreen Roth Henig

Kezar Life Sciences, Inc.

Dr. Henig stepped down as CMO effective Oct 6, 2023; separation agreement signed Oct 23, 2023.
Cash severance: 12 months base salary plus 40% of target bonus, paid over 12 months.
Reimbursement of up to 12 months of COBRA premiums; vested stock option exercise extended to Dec 31, 2024.
Severance contingent on a general release of claims effective Oct 31, 2024.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Noreen Roth Henig

Chief Medical Officer

KZR · Kezar Life Sciences, Inc.

Effective: 2023-10-06
Filed: October 27, 2023, 7:59 PM ET

On September 30, 2023, as previously announced, the board of directors of Kezar Life Sciences, Inc. (the “Company”) and Noreen Roth Henig, M.D., the Company’s former Chief Medical Officer, reached the mutual decision for Dr. Henig to step down as Chief Medical Officer effective October 6, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Noreen Roth Henig departed as Chief Medical Officer at Kezar Life Sciences, Inc..

Action: stepped down
Role: Chief Medical Officer

Exact text from the filing

On September 30, 2023, as previously announced, the board of directors of Kezar Life Sciences, Inc. (the “Company”) and Noreen Roth Henig, M.D., the Company’s former Chief Medical Officer, reached the mutual decision for Dr. Henig to step down as Chief Medical Officer effective October 6, 2023.

View on SEC.gov

Kezar Life Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-055985

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.